GO:0014808 release of sequestered calcium ion into cytosol by sarcoplasmic reticulum: Calcium Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0014808 describes the release of calcium ions that were previously sequestered inside the sarcoplasmic reticulum (SR) back into the cytosol through dedicated calcium release channels.
• This process is essential for excitation-contraction coupling in cardiac, skeletal, and vascular smooth muscle, converting an electrical or receptor signal into a rise in cytosolic calcium.
• Ryanodine receptors (RYR1, RYR2, RYR3) and inositol 1,4,5-trisphosphate receptors (ITPR1-3) are the principal SR calcium release channels that execute this process.
• The SR calcium store is maintained by SERCA pumps (ATP2A1-3), which import calcium and thereby set the size of the releasable pool.
• Dysregulated SR calcium release is linked to cardiac arrhythmias, heart failure, skeletal muscle disorders, and vascular dysfunction.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of SR calcium release genes in disease and drug discovery.
Description
The release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0014808) is the biological process in which calcium ions stored inside the sarcoplasmic reticulum (SR) are discharged into the cytosol through calcium release channels. This process is a central node in intracellular calcium signaling and is required for the contraction of cardiac, skeletal, and vascular smooth muscle, as well as for many non-muscle cell functions. The SR acts as a dynamic calcium reservoir; its loading depends on the sarcoplasmic reticulum Ca2+-ATPase (SERCA), which pumps cytosolic calcium into the SR lumen, and its discharge depends on release channels such as ryanodine receptors (RYRs) and inositol 1,4,5-trisphosphate receptors (ITPRs). Because the SR membrane separates a high-calcium lumen from a low-calcium cytosol, opening of release channels produces a rapid and large increase in cytosolic calcium that can be decoded by downstream effectors. For researchers, GO:0014808 is important because it defines the specific step at which stored calcium becomes available for signaling. Experimental work in vascular smooth muscle has shown that SR calcium uptake and release are tightly coupled to MgATP availability and to receptor signaling, including angiotensin receptor pathways. In cardiac and skeletal muscle, the interaction between SR calcium release channels and accessory proteins, as well as modulation by nitric oxide, shapes the amplitude and duration of the calcium transient. Consequently, genes that control SR calcium release are prime candidates in cardiovascular, musculoskeletal, and metabolic disease research. This article summarizes the authoritative definition of GO:0014808, the molecular machinery that carries it out, the genes and proteins involved, and the experimental methods used to study it. It is written for scientists who need a precise, citation-backed overview that can support grant writing, target validation, and the design of CRISPR-based cell models.
release of sequestered calcium ion into cytosol by sarcoplasmic reticulum At A Glance
| GO ID | GO:0014808 |
|---|---|
| GO term | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum |
| Ontology | biological_process |
| Synonym | release of sequestered calcium ion by sarcoplasmic reticulum into cytosol |
| Major function | Discharge of SR-stored calcium into the cytosol through calcium release channels |
| Cellular location | Sarcoplasmic reticulum membrane |
| Key channels | Ryanodine receptors (RYR1, RYR2, RYR3) and inositol 1,4,5-trisphosphate receptors (ITPR1-3) |
| Upstream store loading | SERCA pumps (ATP2A1, ATP2A2, ATP2A3) import calcium into the SR lumen |
| Physiological impact | Excitation-contraction coupling, calcium signaling, and muscle contraction |
What Is GO:0014808?
GO:0014808 is defined as the process in which the release of sequestered calcium ion by sarcoplasmic reticulum into cytosol occurs via calcium release channels. In other words, it is the calcium-release step that moves calcium ions out of the SR lumen and into the cytosol through channel proteins embedded in the SR membrane, rather than the upstream uptake step or downstream cytosolic buffering steps.
Why Is release of sequestered calcium ion into cytosol by sarcoplasmic reticulum Important in Cell Biology?
GO:0014808 is important because it is the point at which the sarcoplasmic reticulum converts a stored calcium pool into a fast cytosolic signal. This step underlies excitation-contraction coupling in cardiac, skeletal, and vascular smooth muscle, and it participates in receptor-driven calcium signaling in many cell types. Because the SR calcium store is maintained by SERCA-mediated uptake and consumed by channel-mediated release, the balance between these activities determines the shape of the calcium transient and the strength of downstream responses. Defects in SR calcium release channels or their regulators are associated with arrhythmias, heart failure, and muscle dysfunction, making this process a major focus of translational research.
• Provides the calcium signal required for cardiac and skeletal muscle contraction.
• Links receptor signaling, including angiotensin receptor activation, to intracellular calcium elevation in vascular smooth muscle.
• Depends on the SR calcium gradient established by SERCA pumps, making it sensitive to energy metabolism and ATP supply.
• Is modulated by nitric oxide and redox signals acting on ryanodine receptors.
• Is a source of calcium for cytosolic effectors that control contraction, secretion, and gene expression.
• Dysregulation contributes to cardiac arrhythmias and contractile failure.
• Is relevant to ischemic and reperfused myocardium, where membrane abnormalities can alter calcium handling.
• Provides a tractable target for CRISPR-based functional genomics of calcium handling genes.
• Can be modeled in cultured vascular smooth muscle cells and cardiomyocytes for drug testing.
• Serves as a readout for SR integrity and calcium store content in physiological experiments.
What Happens During release of sequestered calcium ion into cytosol by sarcoplasmic reticulum?
Step 1: Maintenance of the SR calcium store
In simple terms: Before calcium can be released, it must first be pumped into the sarcoplasmic reticulum and stored there.
The sarcoplasmic reticulum maintains a high luminal calcium concentration through the activity of SERCA-type Ca2+-ATPases, which couple ATP hydrolysis to calcium transport across the SR membrane. In vascular smooth muscle, calcium uptake by the SR occurs through both MgATP-dependent and MgATP-independent mechanisms, indicating that store loading is metabolically sensitive. This stored calcium constitutes the sequestered pool that is later released into the cytosol during GO:0014808.
Step 2: Opening of SR calcium release channels
In simple terms: When the cell receives the right signal, channel proteins in the SR membrane open like gates and let stored calcium flow out.
Calcium release from the SR occurs via calcium release channels, principally ryanodine receptors and inositol 1,4,5-trisphosphate receptors. In cardiac and skeletal muscle, ryanodine receptors are the dominant release channels, and their opening is influenced by cytosolic calcium, nucleotides, and interacting proteins. In vascular smooth muscle, receptor signaling pathways such as angiotensin receptor activation can trigger SR calcium release, linking extracellular signals to cytosolic calcium elevation.
Step 3: Calcium flux into the cytosol
In simple terms: Once the channels open, calcium moves down its concentration gradient from the SR lumen into the cytosol.
Because the SR lumen contains a much higher calcium concentration than the cytosol, opening of release channels allows a rapid downhill flux of calcium into the cytosol. This flux is the defining event of GO:0014808 and produces the cytosolic calcium transient that drives contraction and other calcium-dependent processes. The magnitude and kinetics of this flux depend on the size of the stored calcium pool and the open probability of the release channels.
Step 4: Modulation by nitric oxide and redox signals
In simple terms: Small signaling molecules such as nitric oxide can tune how easily the release channels open.
Nitric oxide interacts with ryanodine receptors of skeletal and cardiac sarcoplasmic reticulum, providing a molecular mechanism for modulation of SR calcium release. This modulation can alter channel activity and thereby shape the calcium transient generated by GO:0014808. Such regulation is relevant to physiological conditions and to disease states in which redox balance is disturbed.
Step 5: Termination and recycling of calcium
In simple terms: After release, calcium is removed from the cytosol so the signal can end and the store can be refilled.
Termination of the cytosolic calcium signal requires removal of calcium from the cytosol, either back into the SR via SERCA pumps or out of the cell by other transporters. In vascular smooth muscle, SR calcium uptake mechanisms contribute to the restoration of the store after release. This recycling step ensures that the SR remains competent for subsequent rounds of GO:0014808.
Key Genes Involved in GO:0014808 release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
The genes most directly implicated in GO:0014808 encode the SR calcium release channels, their accessory regulators, and the pumps that maintain the releasable calcium store.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RYR1 | Skeletal muscle ryanodine receptor calcium release channel | Central to skeletal muscle excitation-contraction coupling and SR calcium release |
| RYR2 | Cardiac ryanodine receptor calcium release channel | Key mediator of cardiac SR calcium release and arrhythmia research |
| RYR3 | Ryanodine receptor isoform expressed in multiple tissues | Contributes to SR calcium release in non-cardiac and smooth muscle contexts |
| ITPR1 | Inositol 1,4,5-trisphosphate receptor calcium release channel | Mediates IP3-dependent SR calcium release in many cell types |
| ITPR2 | Inositol 1,4,5-trisphosphate receptor isoform | Participates in receptor-driven SR calcium release |
| ITPR3 | Inositol 1,4,5-trisphosphate receptor isoform | Contributes to SR calcium release in secretory and smooth muscle cells |
| ATP2A1 | SERCA1 calcium pump that loads the SR | Sets the size of the releasable calcium store in skeletal muscle |
| ATP2A2 | SERCA2 calcium pump that loads the SR | Maintains SR calcium content for cardiac and smooth muscle release |
| ATP2A3 | SERCA3 calcium pump isoform | Contributes to SR calcium store maintenance in non-muscle cells |
| CALM1 | Calmodulin, calcium sensor that regulates channels | Modulates ryanodine receptor and calcium signaling activity |
| CALM2 | Calmodulin isoform involved in calcium signaling | Regulates calcium-dependent modulation of SR release channels |
| CALM3 | Calmodulin isoform involved in calcium signaling | Participates in calcium-dependent regulation of SR calcium release |
| FKBP1A | FK506-binding protein that associates with ryanodine receptors | Modulates ryanodine receptor channel stability and calcium release |
| NOS1 | Neuronal nitric oxide synthase | Produces nitric oxide that modulates ryanodine receptors |
| NOS3 | Endothelial nitric oxide synthase | Contributes to nitric oxide signaling that influences SR calcium release |
| AGTR1 | Angiotensin II receptor type 1 | Links angiotensin signaling to SR calcium release in vascular smooth muscle |
| PLN | Phospholamban, regulator of SERCA | Modulates SR calcium uptake and thereby the releasable store |
How Is release of sequestered calcium ion into cytosol by sarcoplasmic reticulum Regulated?
GO:0014808 is regulated at multiple levels. The size of the releasable calcium store is set by SERCA-mediated uptake, which is sensitive to ATP availability and to regulators such as phospholamban. Channel opening is controlled by cytosolic calcium, nucleotides, and accessory proteins, and is further modulated by nitric oxide acting on ryanodine receptors. Receptor signaling pathways, including angiotensin receptor activation, can trigger SR calcium release in vascular smooth muscle, linking extracellular stimuli to this process. In ischemic and reperfused myocardium, membrane abnormalities and endogenous amphiphiles may alter SR calcium handling, providing an additional layer of pathophysiological regulation.
release of sequestered calcium ion into cytosol by sarcoplasmic reticulum and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RYR2 | Cardiac arrhythmia and heart failure | Cardiomyocyte knockout or point-mutation model |
| RYR1 | Skeletal muscle dysfunction | Skeletal myotube knockout or knock-in model |
| ITPR1 | Receptor-driven calcium signaling disorders | Knockout cell line with calcium imaging |
| ATP2A2 | SR calcium store maintenance in cardiac and smooth muscle | SERCA2 knockout or overexpression model |
| AGTR1 | Vascular dysfunction and hypertension | Vascular smooth muscle cell knockout model |
Cardiac arrhythmias and heart failure
Dysregulated SR calcium release through ryanodine receptors can produce abnormal cytosolic calcium transients that predispose to cardiac arrhythmias and contribute to contractile dysfunction in heart failure. Nitric oxide modulation of ryanodine receptors is one mechanism that can alter channel behavior in cardiac tissue. Because GO:0014808 defines the release step, proteins that control this process are candidate therapeutic targets and biomarkers in cardiac disease.
Skeletal muscle disorders
In skeletal muscle, SR calcium release through RYR1 is required for contraction, and altered channel regulation can impair muscle function. Nitric oxide interaction with skeletal muscle ryanodine receptors provides a molecular link between redox signaling and SR calcium release. Studying GO:0014808 in skeletal muscle models can help clarify how release channel dysfunction contributes to muscle disease.
Vascular dysfunction and hypertension
In vascular smooth muscle, SR calcium uptake and release are coupled to MgATP-dependent and MgATP-independent mechanisms, and receptor signaling such as angiotensin receptor activation can trigger SR calcium release. These pathways influence vascular tone and are relevant to hypertension and vascular remodeling. GO:0014808 therefore provides a framework for studying how SR calcium handling contributes to vascular disease.
Ischemic and reperfused myocardium
Ischemia and reperfusion are associated with membrane abnormalities in the myocardium, and endogenous amphiphiles have been proposed to contribute to these changes. Such membrane alterations can affect SR calcium handling and the release of sequestered calcium into the cytosol. This makes GO:0014808 relevant to understanding calcium overload and injury during ischemic events.
From release of sequestered calcium ion into cytosol by sarcoplasmic reticulum-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of RYR2 abolish cardiac SR calcium release? | RYR2 knockout cardiomyocyte model |
| Does a point mutation alter ryanodine receptor channel gating? | Point-mutation knock-in cell model |
| Can a tagged release channel be tracked in live cells? | Tagged knock-in of RYR2 or ITPR1 |
| Does overexpression of SERCA increase the releasable calcium store? | ATP2A2 overexpression cell model |
| Does angiotensin receptor signaling require ITPR-mediated SR release? | AGTR1 knockout with ITPR knockdown |
| Does nitric oxide modulation change SR calcium release? | NOS1 or NOS3 knockout cell model |
How to Study the release of sequestered calcium ion into cytosol by sarcoplasmic reticulum Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescent calcium imaging | Cytosolic calcium transients | Measuring SR calcium release in live cells |
| Caffeine-induced release assay | SR calcium store content | Quantifying the releasable calcium pool |
| Single-channel electrophysiology | Ryanodine receptor or ITPR channel activity | Testing channel modulation by nitric oxide or ligands |
| ATP-dependent uptake assay | SERCA-mediated SR calcium loading | Assessing store maintenance before release |
| Receptor agonist stimulation | Signaling-dependent SR calcium release | Studying angiotensin receptor pathways |
| Membrane fractionation | SR membrane integrity and protein composition | Analyzing ischemic membrane abnormalities |
| CRISPR knockout screening | Gene requirement for SR calcium release | Identifying novel regulators of GO:0014808 |
| Live-cell FRET sensors | Real-time calcium dynamics in subcellular compartments | Tracking SR-to-cytosol calcium flux |
Calcium imaging
Live-cell calcium imaging with fluorescent indicators allows direct measurement of cytosolic calcium transients generated by GO:0014808. This approach has been used to study SR calcium uptake and release in vascular smooth muscle and cardiac preparations. Imaging can be combined with receptor agonists such as angiotensin II to probe signaling-dependent release.
SR calcium content assays
Measurements of SR calcium content, for example by caffeine-induced release or by direct luminal calcium probes, quantify the size of the sequestered pool that is available for release. Such assays distinguish defects in store loading from defects in channel opening.
Electrophysiology and channel activity
Single-channel or macroscopic current recordings can measure the activity of SR calcium release channels such as ryanodine receptors and ITPRs. These methods reveal how modulators like nitric oxide alter channel open probability and thereby GO:0014808.
Genetic and pharmacological perturbation
Knockout, knockdown, or pharmacological inhibition of release channels and pumps can test causality in GO:0014808. Studies of MgATP-dependent and MgATP-independent SR calcium uptake illustrate how metabolic and pharmacological perturbations reveal distinct transport mechanisms. Such experiments are essential for linking specific genes to SR calcium release phenotypes.
How CRISPR Can Be Used to Study GO:0014808 release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
Knockout
CRISPR knockout of genes such as RYR2, RYR1, or ITPR1 can abolish or reduce SR calcium release, providing causal evidence for their role in GO:0014808. Knockout models are also useful for testing whether SERCA pumps are required to maintain the releasable store.
Point Mutation
Point-mutation knock-in can mimic disease-associated variants in release channels or pumps and reveal how specific residues control channel gating or calcium transport. Such models are valuable for dissecting the molecular determinants of SR calcium release.
Knock-in
Tagged knock-in of release channel genes allows live-cell tracking and biochemical isolation of channel complexes. This approach can define the composition of SR calcium release machinery and its dynamic regulation.
Overexpression
Overexpression of SERCA or release channels can increase or alter SR calcium release capacity, enabling gain-of-function studies of GO:0014808. Overexpression models are useful for testing whether increased store content translates into larger cytosolic calcium transients.
How EDITGENE Supports release of sequestered calcium ion into cytosol by sarcoplasmic reticulum Research
Researchers studying release of sequestered calcium ion into cytosol by sarcoplasmic reticulum-related genes often need to determine whether a candidate gene is causally involved in SR calcium release, whether a specific variant alters channel or pump function, and how the process behaves in a relevant cell background. EDITGENE provides CRISPR-based cell models and screening services designed to answer these questions with reproducible, publication-ready data.
Contact EDITGENE today to design your custom CRISPR model for release of sequestered calcium ion into cytosol by sarcoplasmic reticulum research.
Frequently Asked Questions About release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
What is GO:0014808?
GO:0014808 is the biological process in which sequestered calcium ion is released from the sarcoplasmic reticulum into the cytosol via calcium release channels.
What happens during release of sequestered calcium ion into cytosol by sarcoplasmic reticulum?
Stored calcium in the SR lumen flows through open release channels into the cytosol, generating a calcium transient that drives contraction and signaling.
What genes are involved in release of sequestered calcium ion into cytosol by sarcoplasmic reticulum?
Key genes include RYR1, RYR2, RYR3, ITPR1, ITPR2, ITPR3, ATP2A1, ATP2A2, ATP2A3, and regulators such as CALM1, FKBP1A, NOS1, NOS3, AGTR1, and PLN.
Which channels mediate SR calcium release?
Ryanodine receptors and inositol 1,4,5-trisphosphate receptors are the principal SR calcium release channels.
How is the SR calcium store maintained?
SERCA-type Ca2+-ATPases pump calcium into the SR lumen, and this uptake can be MgATP-dependent or MgATP-independent depending on the tissue.
Why is SR calcium release important for muscle contraction?
The calcium released into the cytosol activates contractile machinery, making GO:0014808 a required step in excitation-contraction coupling.
How is SR calcium release regulated?
It is regulated by store content, channel modulators such as calcium and nucleotides, accessory proteins, nitric oxide, and receptor signaling pathways.
What diseases are linked to SR calcium release?
Cardiac arrhythmias, heart failure, skeletal muscle dysfunction, vascular disorders, and ischemic myocardial injury have been associated with altered SR calcium handling.
How can CRISPR help study GO:0014808?
CRISPR knockout, point mutation, knock-in, and overexpression models can test the causal role of specific genes and variants in SR calcium release.
What methods measure SR calcium release?
Fluorescent calcium imaging, caffeine-induced release assays, electrophysiology, ATP-dependent uptake assays, and receptor agonist stimulation are commonly used.
Conclusion
GO:0014808 defines the release of sequestered calcium from the sarcoplasmic reticulum into the cytosol through calcium release channels, a process that is central to muscle contraction, receptor signaling, and calcium homeostasis. The genes encoding ryanodine receptors, ITP receptors, SERCA pumps, and their regulators form the molecular machinery that executes and controls this process. Because dysregulation of SR calcium release is linked to cardiac, skeletal muscle, and vascular disease, this GO term provides a useful framework for target discovery and functional validation. CRISPR-based cell models and screening approaches offer a direct route to test causality and to build publication-ready evidence for genes involved in GO:0014808.
References
- 1. Bublitz M et al.. 2013. Ion pathways in the sarcoplasmic reticulum Ca2+-ATPase.. J Biol Chem 288(15):10759-65 PMID: 23400778
- 2. Stout MA. 1991. Calcium transport by sarcoplasmic reticulum of vascular smooth muscle: I. MgATP-dependent and MgATP-independent calcium uptake.. J Cell Physiol 149(3):383-95 PMID: 1744170
- 3. Spencer CI et al.. 2000. Loading of calcium and strontium into the sarcoplasmic reticulum in rat ventricular muscle.. J Mol Cell Cardiol 32(7):1285-300 PMID: 10860770
- 4. Salama G et al.. 2000. Molecular interaction between nitric oxide and ryanodine receptors of skeletal and cardiac sarcoplasmic reticulum.. Antioxid Redox Signal 2(1):5-16 PMID: 11232600
- 5. Smith JB. 1986. Angiotensin-receptor signaling in cultured vascular smooth muscle cells.. Am J Physiol 250(5 Pt 2):F759-69 PMID: 2422956
- 6. Messineo FC. 1983. The possible role of endogenous amphiphiles in the membrane abnormalities of ischemic and reperfused myocardium.. Am J Emerg Med 1(2):162-7 PMID: 6680616
